170 related articles for article (PubMed ID: 9641482)
21. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
[TBL] [Abstract][Full Text] [Related]
22. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
Yuan CS; Foss JF
Neuropharmacology; 1999 Mar; 38(3):425-32. PubMed ID: 10219980
[TBL] [Abstract][Full Text] [Related]
23. Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.
Garaulet JV; Laorden ML; Milanés MV
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):72-9. PubMed ID: 8832591
[TBL] [Abstract][Full Text] [Related]
24. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
25. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
26. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
Yu XC; Li HY; Wang HX; Wong TM
J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone modulates hypotension induced by opioids in anaesthetised rats.
Sorrentino R; Capasso A; d'Emmanuele di Villa Bianca R; Pinto A
Eur J Pharmacol; 2001 Oct; 430(1):79-85. PubMed ID: 11698066
[TBL] [Abstract][Full Text] [Related]
28. Opioid regulation of mucosal ion transport in the mouse isolated jejunum.
Sheldon RJ; Rivière PJ; Malarchik ME; Moseberg HI; Burks TF; Porreca F
J Pharmacol Exp Ther; 1990 Apr; 253(1):144-51. PubMed ID: 2329501
[TBL] [Abstract][Full Text] [Related]
29. Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by mu, kappa and delta opioid agonists in isolated tissues.
Capasso A
Neuropharmacology; 1999 Jun; 38(6):871-7. PubMed ID: 10465690
[TBL] [Abstract][Full Text] [Related]
30. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1997 Apr; 281(1):129-35. PubMed ID: 9103489
[TBL] [Abstract][Full Text] [Related]
31. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
[TBL] [Abstract][Full Text] [Related]
33. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
34. Differential antagonism of mu agonists by U50,488H in the rat.
Porreca F; Tortella FC
Life Sci; 1987 Dec; 41(23):2511-6. PubMed ID: 2824958
[TBL] [Abstract][Full Text] [Related]
35. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
36. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
37. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
Sheldon RJ; Nunan L; Porreca F
Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
[TBL] [Abstract][Full Text] [Related]
38. Behavioral effects of systemically administered mu and kappa opioid agonists in the squirrel monkey: peptides versus alkaloids.
Jones DN; Holtzman SG
Pharmacol Biochem Behav; 1994 Mar; 47(3):421-6. PubMed ID: 7911572
[TBL] [Abstract][Full Text] [Related]
39. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]